David Beal
Just Landed
New Today
Funded PhD in Protein Hydras for Cancer Therapy at University of Kent University of Kent in United Kingdom
Degree Level
PhD
Field of study
Biochemistry
Funding
Funded PhD with tuition fees covered and a stipend of £21,805 per year. Funding is only applicable for UK students.
Deadline
Oct 23, 2026
Country
United Kingdom
University
University of Kent

How do I apply for this?
Sign in for free to reveal details, requirements, and source links.
Apply for this position
Keywords
Suggested positions
About this position
Funded PhD opportunity at the University of Kent in the Beal lab, working with David Beal and Michelle D. Garrett on Protein Hydras for cancer therapy.
The project focuses on the development of therapeutically important antibodies and antibody drug conjugates (ADC), especially bispecifics and polymodified ADC. This is a strong fit for students interested in chemical biology, chemical synthesis, molecular biology, biochemistry, and recombinant protein production.
Funding: Tuition fees and a stipend of £21,805 per year. The funding is only applicable for UK students.
Deadline: 23 October 2026. Project start: January 2027.
Interested applicants should contact [email protected] for further information and follow the application instructions at the provided link.
Funding details
Funded PhD with tuition fees covered and a stipend of £21,805 per year. Funding is only applicable for UK students.
What's required
Applicants should be UK students, as the funding is only applicable for UK students. The project is a PhD by research and is suited to candidates interested in chemical synthesis, molecular biology, biochemistry, and recombinant protein production.
How to apply
Contact David Beal for further information about the project. Use the provided application information link to learn how to apply and submit the PhD application before the deadline.
More information can be found here
Ask ApplyKite AI
Professors

How do I apply for this?
Sign in for free to reveal details, requirements, and source links.